Our clear focus is to rapidly build shareholder wealth by taking our device to initial clinical trials at which stage we will look to align ourselves with a multinational medical device company, or seek additional funding to bring the device to market. There are a number of major medical device companies developing and, in limited instances, selling artificial heart assist devices. BiVACOR® represents a “ground change” which will position an acquirer with a major market opportunity.

We are a limited liability company interested in engaging commercial collaboration to support this process. For information or discussion about supporting the BiVACOR® system please contact us.